Healthcare entity
Of the tracked stories, 1 of 2 also mention Arri Coomarasamy, the most common co-covered peer. Across a 106-day span, the pace is roughly 0.1 stories per week. The 7.5 average consequence score is above the beat benchmark of 6.2 in the same window.
Last mentioned: Mar 17, 2026
Entity pulse
Coverage balance Balanced directional read. Positive and negative coverage are within 0 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Of the tracked stories, 1 of 2 also mention Arri Coomarasamy, the most common co-covered peer. Across a 106-day span, the pace is roughly 0.1 stories per week. The 7.5 average consequence score is above the beat benchmark of 6.2 in the same window. They are less corroborated than the beat average, carrying 2 original sources each against 3.7 for the same window. Coverage clusters in market-trends, which accounts for 1 of those 2, with the remainder spread across 1 other category. We currently track 2 Healthcare stories that mention The Lancet, published between March 17, 2026 and June 30, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 297 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering The Lancet. Shared-story counts are live from our verified record — not editorial picks.
Lancet Series on Postpartum Haemorrhage Published
The Lancet releases a three-part series consolidating evidence on PPH, the E-MOTIVE strategy, and implementation guidance, with a special emphasis on high-burden countries like India.
Mental Health Focus
Cannabis clinics see a surge in patients seeking treatment for anxiety and PTSD.
Clinical Findings Released
The Lancet publishes data showing no significant benefit over placebo for psychiatric conditions.
E-MOTIVE Trial Published
A large cluster-randomized trial across low- and middle-income countries demonstrates that objective blood-loss measurement with a calibrated drape plus a bundled treatment package significantly reduces PPH-related severe morbidity and mortality.
Legalization Milestone
Australia legalizes medicinal cannabis at the federal level, sparking industry growth.
The Lancet series validates the E-MOTIVE bundle as a low-cost, scalable fix for postpartum hemorrhage, which accounts for up to 38% of maternal deaths in India. For healthcare providers, the drape-based early detection and standardized treatment protocol promise to overhaul emergency obstetric workflows and save thousands of lives.
Source: Kirti Pandey (in) · Kirti Pandey (in)
A landmark study published in The Lancet has concluded that medicinal cannabis is no more effective than a placebo in treating anxiety, depression, and PTSD. The findings challenge the multi-billion dollar cannabis industry's reliance on mental health prescriptions and could trigger significant regulatory shifts.
Source: brisbanetimes.com.au · theage.com.au
The Lancet is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
